Newsletter | September 13, 2025

09.13.25 -- Life Science Leader Best Of August

AUGUST'S BEST FEATURED EDITORIAL

What Life Sciences Gets Right (And Misses) About AI

By Anastasia Christianson, Ph.D.

Fear of change is a key limiting factor that is slowing the adoption and value of AI across life sciences. It doesn't have to be that way, writes Anastasia Christianson, Ph.D.

AUGUST'S BEST INDUSTRY INSIGHTS

The Top 5 Myths About eCOA In 2025

Projected to grow 16.1% annually through 2030, eCOA solutions are booming. Uncover myths and misconceptions about eCOAs so your clinical teams can make evidence-based decisions.

Sickle Cell Cure Within Reach, But At A Steep Cost

Treatment options for sickle cell disease (SCD) and newly available gene therapies represent a potential cure. However, the latter are costly and thus remain out of reach for many SCD patients.

Accelerating Gene Therapy Development For NEDAMSS

Discover how one family's race against time led to the creation of a groundbreaking gene therapy for their daughter, just 14 months after her ultra-rare disease diagnosis.